This is the first reported case of concurrent Epstein-Barr-virus-induced hepatitis, acute acalculous cholecystitis, and acute pancreatitis. The patient's full recovery through nonsurgical management, including antiviral and antiinflammatory therapies, may provide valuable insights for future clinical practice.
Wang et al. (Thu,) studied this question.